#$%^&*AU2018203461A120180607.pdf#####Abstract Compositions comprising fucan agents and the use of said compositions in the treatment, prevention, inhibition etc, 5 of fibrous adhesions, peritonitis, ischemia, reperfusion injury, endotoxemia, keloids and keloid trait scarring, dermatitis and rosacea. The preferred fucan agents are characterized by their molecular weight distribution. 8108702_1 (GHMatters) P89657.AU.1 19/08/16